
CelLBxHealth Plc
(LSE) AGL
CelLBxHealth Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.62M
Net Income (TTM)
$15.78M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AGL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CelLBxHealth Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
119
CEO
Andrew D. W. Newland
Website
www.angleplc.comHeadquarters
Guildford, GU2 7AF, GB
AGL Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
N/A
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Payout Ratio
N/A
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.78M
Operating Income
$15.10M
EBITDA
$13.02M
Operating Cash Flow
$13.45M
Capital Expenditure
$444.00K
Free Cash Flow
$13.89M
Cash & ST Invst.
$10.43M
Total Debt
$4.21M
CelLBxHealth Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$398.00K
-23.0%
Gross Profit
$233.00K
-23.7%
Gross Margin
58.54%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
150
N/A
Net Income
$4.63M
-20.2%
EBITDA
$4.62M
-18.6%
Quarterly Fundamentals
Net Cash
$1.60M
-88.3%
Accounts Receivable
$1.68M
-12.5%
Inventory
$1.57M
-10.7%
Long Term Debt
$2.81M
-20.0%
Short Term Debt
$1.71M
+20.9%
Return on Assets
N/A
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
$2.34M
+32.2%
Operating Cash Flow
$2.30M
+32.3%